Copyright
©2012 Baishideng Publishing Group Co.
World J Radiol. Nov 18, 2012; 4(11): 443-449
Published online Nov 18, 2012. doi: 10.4329/wjr.v4.i11.443
Published online Nov 18, 2012. doi: 10.4329/wjr.v4.i11.443
Skin | Epidermis | Dermis | Subdermis | |
Reference point | Depth from the skin surface (mm) | 0.1 | 2.5 | 5 |
EBRT | Dose (cGy) | 36 | 48 | 54 |
Equivalent dose* - a | 40 | 48 | 57.1 | |
BT without spacer | Dose (cGy) | 9.3 | 8 | 12.5 |
Equivalent dose* - b | 22.9 | 17.6 | 41.6 | |
Cumulative dose of a + b | 62.9 | 65.6 | 98.7 | |
BT with spacer | Dose (cGy) | 1.8 | 4.4 | 6.7 |
Equivalent dose* - c | 1.73 | 6.51 | 12.9 | |
Cumulative dose of a + c | 41.73 | 54.51 | 70 | |
Ratio of dose reduction in equivalent dose*: c/b | EQD2, α/β = 3 (cGy) | 1/13.2 | 1/2.7 | 1/3.22 |
- Citation: Kishi K, Tanino H, Sonomura T, Shirai S, Noda Y, Sato M, Okamura Y. Novel eradicative high-dose rate brachytherapy for internal mammary lymph node metastasis from breast cancer. World J Radiol 2012; 4(11): 443-449
- URL: https://www.wjgnet.com/1949-8470/full/v4/i11/443.htm
- DOI: https://dx.doi.org/10.4329/wjr.v4.i11.443